Article Information
History
- February 11, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Christian Gaebler1,
- Justin DaSilva2,
- Eva Bednarski2,
- Frauke Muecksch2,
- Fabian Schmidt1,
- Yiska Weisblum1,
- Katrina G. Millard1,
- Martina Turroja1,
- Alice Cho1,
- Zijun Wang1,
- Marina Caskey1,
- Michel C. Nussenzweig1,3,*,
- Paul D. Bieniasz1,3,* and
- Theodora Hatziioannou1,*
- 1Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA
- 2Laboratory of Retrovirology, The Rockefeller University, New York, NY 10065, USA
- 3Howard Hughes Medical Institute
- ↵*Corresponding authors. Email: nussen{at}rockefeller.edu or thatziio{at}rockefeller.edu, or pbieniasz{at}rockefeller.edu
Posted February 11, 2022.
SARS-CoV-2 neutralization after mRNA vaccination and variant breakthrough infection
